WHO ICTRP trial

The Relationship of single nucleotide polymorphisms in the Interleukin-7…

ACTRN12605000495628 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12605000495628
Public title The Relationship of single nucleotide polymorphisms in the Interleukin-7 receptor-alpha gene to CD4+ immune recovery in HIV infected patients who begin antiretroviral treatment with HAART
Scientific title The Relationship of single nucleotide polymorphisms in the Interleukin-7 receptor-gene to CD4+ immune recovery in HIV infected patients who begin antiretroviral treatment with HAART
Primary sponsor NHMRC
Secondary sponsors New secondary sponsor name. Please modify.
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Observational
Phase Not Applicable
Countries Australia
Conditions The determinants of immune recovery following institution of Highly Active Antiretroviral Treatment in HIV infected patients; The determinants of immune recovery following institution of Highly Active Antiretroviral Treatment in HIV…
Interventions None. This is an observational study.
Registration date Sep 23, 2005
Target size 110
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations